| Valproic acid | Approved Investigational | C1QTNF4 | 114900 |
downregulated | Valproic Acid results in decreased expression of C1QTNF4 mRNA | 11p11.2 | |
| Valproic acid | Approved Investigational | C1QTNF7 | 114905 |
downregulated | Valproic Acid results in decreased expression of C1QTNF7 mRNA | 4p15.32 | |
| Valproic acid | Approved Investigational | C1RL | 51279 |
downregulated | Valproic Acid results in decreased expression of C1RL mRNA | 12p13.31 | |
| Valproic acid | Approved Investigational | C1RL | 51279 |
upregulated | Valproic Acid results in increased expression of C1RL mRNA | 12p13.31 | |
| Valproic acid | Approved Investigational | C1S | 716 |
downregulated | Valproic Acid results in decreased expression of C1S mRNA | 12p13.31 | |
| Valproic acid | Approved Investigational | C2CD2 | 25966 |
downregulated | Valproic Acid results in decreased expression of C2CD2 mRNA | 21q22.3 | |
| Valproic acid | Approved Investigational | C2CD2 | 25966 |
upregulated | Valproic Acid results in increased expression of C2CD2 mRNA | 21q22.3 | |
| Valproic acid | Approved Investigational | C2CD5 | 9847 |
downregulated | Valproic Acid results in decreased expression of C2CD5 mRNA | 12p12.1 | |
| Valproic acid | Approved Investigational | CA11 | 770 |
downregulated | Valproic Acid results in decreased expression of CA11 mRNA | 19q13.33 | |
| Valproic acid | Approved Investigational | CA12 | 771 |
upregulated | Valproic Acid results in increased expression of CA12 mRNA | 15q22.2 | |
| Valproic acid | Approved Investigational | CA13 | 377677 |
upregulated | Valproic Acid results in increased expression of CA13 mRNA | 8q21.2 | |
| Valproic acid | Approved Investigational | CA14 | 23632 |
downregulated | Valproic Acid results in decreased expression of CA14 mRNA | 1q21.2 | |
| Valproic acid | Approved Investigational | CA2 | 760 |
upregulated | Valproic Acid results in increased expression of CA2 mRNA | 8q21.2 | |
| Valproic acid | Approved Investigational | CA3 | 761 |
upregulated | Valproic Acid results in increased expression of CA3 mRNA | 8q21.2 | |
| Valproic acid | Approved Investigational | CA4 | 762 |
downregulated | Valproic Acid results in decreased expression of CA4 mRNA | 17q23.1 | |
| Valproic acid | Approved Investigational | CA4 | 762 |
upregulated | Valproic Acid results in increased expression of CA4 mRNA | 17q23.1 | |
| Valproic acid | Approved Investigational | CA8 | 767 |
upregulated | Valproic Acid results in increased expression of CA8 mRNA | 8q12.1 | |
| Valproic acid | Approved Investigational | CAB39L | 81617 |
downregulated | Valproic Acid results in decreased expression of CAB39L mRNA | 13q14.2 | |
| Valproic acid | Approved Investigational | CAB39L | 81617 |
upregulated | Valproic Acid results in increased expression of CAB39L mRNA | 13q14.2 | |
| Valproic acid | Approved Investigational | CABS1 | 85438 |
downregulated | Valproic Acid results in decreased expression of CABS1 mRNA | 4q13.3 | |
| Valproic acid | Approved Investigational | CACHD1 | 57685 |
downregulated | Valproic Acid results in decreased expression of CACHD1 mRNA | 1p31.3 | |
| Valproic acid | Approved Investigational | CACHD1 | 57685 |
upregulated | Valproic Acid results in increased expression of CACHD1 mRNA | 1p31.3 | |
| Valproic acid | Approved Investigational | CACNA1A | 773 |
upregulated | Valproic Acid results in increased expression of CACNA1A mRNA | 19p13.13 | |
| Valproic acid | Approved Investigational | CACNA1B | 774 |
upregulated | Valproic Acid results in increased expression of CACNA1B mRNA | 9q34.3 | |
| Valproic acid | Approved Investigational | CACNA1E | 777 |
upregulated | Valproic Acid results in increased expression of CACNA1E mRNA | 1q25.3 | |